Actualités et Événements

After the success of the European program REBORNE (FP7) focused on safety and efficacy of the Biomatlante matrix combined with autologous bone marrow expanded mesenchymal stem cells (MSC), MBCP+™, made from our well-known MBCP Technology, was confirmed as the adapted matrix for tissue engineering and chosen for 2 new European research programs (H2020): MAXIBONE and ORTHOUNION.

Introduction: Bone is the most transplanted tissue in human with about 1 million procedures annually in Europe. Autologous bone grafting is the gold standard in bone regeneration but it requires a second surgery, is limited in quantity and often associated with painful complications. Synthetic calcium phosphate biomaterial in association with mesenchymal stem cells may be a potent alternative to autologous bone grafting.

Upcoming Events

Bioregate - FSSCR

Image

AAOS 2019

AAOS 2019

IDS 2019

Image

EUROSPINE 2019

AAOS 2019
biomatlante-logo-white-color.png
Biomatlante a été à l'avant-garde du développement d'une nouvelle greffe osseuse synthétique. 

5 Rue Edouard Belin, 44360 Vigneux-de-Bretagne, France
+33 2 28 02 00 09
Contact@biomatlante.com


Nos produits

Plus

© Copyright 2018 Biomatlante. All Rights Reserved.

Search

Professionnels de santé seulement

Ce site est destiné aux professionnels de la santé.
Vous devez confirmer que vous êtes un professionnel de la santé pour naviguer sur ce site.

Confirmez-vous que vous êtes un professionnel de la santé?